Barinthus Biotherapeutics Plc (BRNS)
0.7401
-0.02
(-2.49%)
USD |
NASDAQ |
Sep 08, 16:00
0.7628
+0.02
(+3.07%)
After-Hours: 20:00
Barinthus Biotherapeutics Max Drawdown (5Y) : 96.82% for Aug. 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| August 31, 2026 | 96.82% |
| July 31, 2026 | 96.82% |
| June 30, 2026 | 96.82% |
| May 31, 2026 | 96.82% |
| April 30, 2026 | 96.82% |
| March 31, 2026 | 96.77% |
| February 28, 2026 | 96.59% |
| January 31, 2026 | 96.15% |
| Date | Value |
|---|---|
| December 31, 2025 | 96.15% |
| November 30, 2025 | 96.15% |
| October 31, 2025 | 96.15% |
| September 30, 2025 | 96.15% |
| August 31, 2025 | 96.15% |
| July 31, 2025 | 96.15% |
| June 30, 2025 | 96.15% |
| May 31, 2025 | 96.15% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Kiniksa Pharmaceuticals International Plc | 75.43% |
| Autolus Therapeutics Plc | 96.58% |
| Scancell Holdings Plc | 99.64% |
| OptiBiotix Health Plc | 100.00% |
| Adaptimmune Therapeutics Plc | 100.00% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -46.35 |
| Beta (5Y) | -0.3671 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 77.82% |
| Historical Sharpe Ratio (5Y) | -0.6384 |
| Historical Sortino (5Y) | -1.282 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 33.55% |